Section Arrow
Quote
HCM.NASDAQ
- HUTCHMED (China) Limited
Quotes are at least 15-min delayed:2025/12/26 20:05 EST
Regular Hours
Last
 13.77
+0.25 (+1.85%)
Day High 
13.885 
Prev. Close
13.52 
1-M High
14.63 
Volume 
27.61K 
Bid
13.72
Ask
13.76
Day Low
13.56 
Open
13.88 
1-M Low
13.0635 
Market Cap 
2.32B 
Currency 美元 
P/E 5.1 
%Yield -- 
10-SMA 13.39 
20-SMA 13.77 
50-SMA 14.46 
52-W High 19.5 
52-W Low 11.505 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.65/0.48
Enterprise Value
2.39B
Balance Sheet
Book Value Per Share
7.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
227.98M
Operating Revenue Per Share
4.41
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.19-0.12-9.16%-- 
HIMSHims & Hers Health34.31-0.36-1.04%65.13PE
IXHLIncannex Healthcare0.3988-0.0118-2.87%-- 
TLRYTilray Brands Inc.9.6-0.55-5.42%-- 
DVAXDynavax Technologies Corp15.38----48.45PE
Industry overview quotes are at least 15 minutes delayed
Business Description
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolioof several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.